Search Weight Loss Topics:

Page 419«..1020..418419420421..430440..»

We need to work together to drive healthier food choices for people and the planet – The Grocer

Posted: November 18, 2020 at 9:53 am

The facts are clear: our food system isnt working as well as it should be for people or planet.

Too many people are going hungry whilst too much food is going to waste. Too many of us are not consuming a balanced diet and too much of the food we eat contributes to greenhouse gas emissions. When I look to the future challenges our children will be facing, it brings it home how much we need to do together to lead for change.

We all know the global food system is unsustainable and unless the average persons diet changes drastically by 2050, we are in danger of depleting the planet. The statistics are sobering: one billion people around the worldare hungry;two billion are obese or overweight; one third of all food produced is thrown away and animal agriculture is the second-largest contributor to greenhouse gas emissions.

We need to move even faster as an industry to build a system which recognises a better for you, better for the planet approach. As part of our new global food strategy, Future Foods, we have two clear objectives: to help people move towards healthier diets and to reduce the environmental impact of our global food chain. We are actioning this by setting ourselves a 1bn sales target for plant-based meat and dairy alternatives in the next five to seven years, raising nutritional standards across our brands and halving food waste in our direct operations by 2025.

These ambitions are grounded in the ethos of our business. In the UK we already have ambitious shared commitments on food waste and carbon reduction as part of the 2025 Courtauld Commitments. Weve also been expanding our plant-based meat and dairy alternatives business for several years, as well as increasing vegan alternatives from our brands.

As a responsible manufacturer, its not only about reducing our impact on the planet and tackling food waste, its about driving healthier choices for people. We understand the urgency with which we need to tackle these issues, and while we cant tell people what to eat, we can offer tastier, healthier and more sustainable foods to choose from.

We are committed to reformulating our products to reduce sugar, salt and calories, as well as reducing portion sizes and creating healthier options. However, its not just about the products we sell, its the way we market them which will help us with this ambition. Simply put, shoppers need to learn about healthier options through advertising and promotions. Thats why we have committed that before the end of 2021 we will also include the healthier version of our core product alongside the core in all of our food and refreshment advertising here in the UK. Were all creatures of habit and we need to be able to inspire and engage in order to get people to try something new.

We absolutely share the governments ambition to tackle the obesity crisis. There is of course a role for regulation, but it needs to be evidence-based, proportionate and have a demonstrable impact on positive outcomes for consumers. Crucially, it needs to provide incentives for manufacturers to invest resources into innovation at a time when this is more important than ever. This incentive is removed if were unable to advertise and promote the vast majority of our reformulated or healthier products, which are included in the governments proposed ban on online advertising and in-store promotions of high fat, salt and sugar foods.

Innovation and renovation is the life-blood of our industry and is fundamental to the positive changes we, as manufacturers, can all lead for. We want to continue to make improvements to our products, tell people about those products and empower people to make responsible choices. We want to use our world-class insight and understanding of our consumers to drive positive behaviour change and encourage people to eat healthier diets.

But more broadly, we want to work hand in hand with retailers, manufacturers, NGOs and government to ensure the UK food ecosystem is more sustainable. We hope these stretching global targets mean Unilever can play a meaningful part in making that happen.

See the rest here:
We need to work together to drive healthier food choices for people and the planet - The Grocer

UNM researchers show gender norms that favor women reverse gender disparities in health – UNM Newsroom

Posted: November 18, 2020 at 9:52 am

Despite the fact that women tend to outlive men in almost all societies, they experience more sickness along the way. This so-called gender-health paradox has long puzzled researchers. Biological differences between the sexes females higher body fat percentage, for example are often presumed to be the reason women are subject to a higher burden of chronic disease. But, as COVID-19s disproportionate effect on womens employment and productivity has made plain, women experience different and often compounding stressors, which can contribute to poorer health.

A new study published in the Proceedings of the National Academy of Sciences points to gender norms as a primary cause of health disparities between men and women. Researchers working among the Mosuo, a minority society in Southwest China, compared communities with two different sets of expectations for household membership and inheritance (called kinship norms).

Siobhn Mattison, assistant professor of Anthropology at The University of New Mexico and director of the Human Family and Evolutionary Demography Lab is the research team leader and has been working in China with the Mosuo since 2016.

Evolutionary Anthropology graduate student Adam Reynolds is the first author of this study, participated in fieldwork in China, and has led numerous analyses, including for this study, to understand how kinship systems affect social and well-being outcomes.

Matrilineal Mosuo typically pass land, home, and wealth from mothers to daughters, who form the backbone of society, with men in more peripheral roles. Patrilineal Mosuo typically pass inheritance from fathers to sons. Because of this, in matrilineal Mosuo communities, women tend to have more autonomy and control of resources. Language, religion, and other cultural beliefs and practices are largely similar across matrilineal and patrilineal Mosuo communities, which makes these factors unlikely explanations of observed differences in health between these communities.

Our work shows that in cultures with norms that favor men, women may have worse health because they experience more stress or adversity than men do.

- Adam Reynolds, Evolutionary Anthropology graduate student

As part of a larger National Science Foundation-funded project, the research brought together an interdisciplinary team of anthropologists, biologists, and demographers from US and Chinese universities to study the impacts of economic change on health and well-being. During two years of data collection, the researchers visited hundreds of Mosuo households in Yunnan Province, interviewing people about their socio-economic circumstances and using blood drawn from finger-pricks as a minimally-invasive method to study participants health.

The researchers leveraged their interdisciplinary expertise to test an old, but under-tested hypothesis that women experience improved health in cultures where they enjoy higher status and empowerment. When the research team, including first author Reynolds, a graduate student of the University of New Mexicos Human Family and Evolutionary Demography Lab, compared matrilineal and patrilineal Mosuo, the difference was striking: women had higher rates of hypertension and inflammation than men in patrilineal communities, but lower rates than men in matrilineal communities.

This is to our knowledge the first time that a complete reversal in markers of chronic disease for men and women has been observed, says Mattison. It suggests that the mainstream biomedical understanding of gender disparities in health may discount the contributions of prevailing gender norms that favor men in most societies. Because there are both matrilineal and patrilineal communities of Mosuo, this unique population provides a kind of natural experiment for testing the effects of fundamental cultural features, such as gender norms, on biology and health, tests that are difficult to perform in most populations studied by biomedical researchers.

The reversal in health disparities was driven by differences in womens health: mens health was roughly similar across the two communities, but women had lower rates of hypertension and inflammation in the matrilineal community. Although the researchers cant pinpoint exactly how differences in gender norms affect health, their analysis suggests that a combination of factors, including better access to resources and kin support for women may be important. This is consistent with work suggesting that empowering women within households and communities improves womens health.

Weve long known that stress is an important factor in health and disease. However, when it comes to gender disparities in health, the common assumption is that hormones and sex chromosomes are the primary culprits, says Reynolds. Our work shows that in cultures with norms that favor men, women may have worse health because they experience more stress or adversity than men do.

People in both patrilineal and matrilineal communities consume rice, pork, and yak butter regularly. Both women and men contribute to agricultural labor. Given the similarities in diet and lifestyle, we were able to isolate kinship norms as our primary unit of comparison," says Chun-Yi Sum, lecturer of social sciences at Boston University, fieldwork team leader, and co-author on the study.

Over their fifteen years of research with the Mosuo, the research team has seen rapid economic development in the region, due primarily to rapidly growing ethnic tourism in the area. Like many other cultures globally, as Mosuo diets and lifestyles change, they are at increasing risk for chronic diseases such as hypertension, obesity, and diabetes. Increasing tourism has led to an influx of wealth, more processed foods in the diet, and sedentary lifestyles that together increase chronic disease risk, says co-author Katherine Wander, assistant professor of anthropology at Binghamton University. As chronic diseases continue to increase in prevalence around the world, our work suggests that women will continue to be disproportionately affected, not because they are inherently more vulnerable, but because gender and kinship norms often disadvantage them.

The authors hope this work will inspire broader thinking about womens health: Even though women live longer lives than men, they dont live healthier lives. Overall, women tend to have higher rates of chronic disease. Our research suggests that this inequality isnt going to be solved purely by biomedicine or typical public health interventions. There is no way to solve these problems without considering the cultural systems that constrain or empower people, Mattison concluded.

Visit link:
UNM researchers show gender norms that favor women reverse gender disparities in health - UNM Newsroom

8 foods and drinks that are common migraine triggers, according to a neurologist – Insider – INSIDER

Posted: November 18, 2020 at 9:52 am

Have you ever wondered if that glass of red wine with dinner might have triggered the pounding headache you felt later that night? The answer might be yes.

"Several studies show a link between food and beverages and migraines," says Thomas Berk, MD, neurologist and headache specialist at NYU Langone Health and Assistant Professor of Neurology at NYU Grossman School of Medicine.

Migraine affects over one billion people worldwide, and 39 million in the US alone. Learn more about the disease, including the most common foods that can trigger a migraine.

The difference between headaches and migraines is largely to do with the severity of the pain.

A headache can be uncomfortable and last for hours to days. Whereas a migraine is considered to be a neurological disease and the most debilitating type of headache, with more than 90% of sufferers incapable of working or doing normal activities during a migraine attack.

"A headache is any kind of pain in the head or face, and there are over 120 different kinds of headaches, which include migraines," says Berk.

A migraine generally includes severe throbbing pain, typically on one side of the head, and it can last from four to 72 hours. Additional symptoms may include sensitivity to light, sound, and smell, nausea, vomiting, and a visual disturbance known as an aura.

"There is no universal food or beverage that triggers migraines," says Berk. Everyone predisposed to migraines has different triggers, some of which may be food or drink-related. Whatever the trigger may be, all migraine triggers affect the brain in the same way by lowering the threshold to migraines.

Here's an example of what could happen. You drink a glass of wine, which is a migraine trigger for you. That drink leads to the creation of inflammatory neurotransmitters that are produced in the brain. Those neurotransmitters make the blood vessels around the brain dilate, and the nerve endings send signals back to the brain to feel symptoms such as pain, sensitivity to light, nausea, and more.

Based on Berk's research and discussions with patients, here is his list of the eight most common foods, drinks, and food-related triggers for migraine headaches:

"Migraine disease is complex and affected by many factors," says Simy Parikh, MD, program director of Thomas Jefferson University's Post-Graduate Certificate Program in Advanced Headache Diagnosis and Management and Assistant Professor in the Department of Neurology at Thomas Jefferson University.

Here Parikh offers some steps you can take to potentially reduce migraine triggers:

Eat healthily and consistently. You may have noticed that the migraine trigger list was lacking a few major food groups "healthy" foods such as fruits, vegetables, and protein, in particular. A 2020 review showed that most "migraine-friendly" healthy eating plans, such as low-fat diets, provided a decrease in the frequency of migraine attacks.

In addition to eating healthy foods, it's important to keep a consistent eating schedule to avoid migraines.

"Low blood glucose can trigger headaches," says Parikh. To keep your blood sugar steady, eat at roughly the same time every day without an extended amount of time between meals, she says. Parikh also suggests to all of her patients to maintain a healthy diet and weight.

Track food triggers and eliminate them from your diet. Since multiple factors contribute to migraines, many sufferers keep a headache diary. This is where they can list the frequency, duration, and intensity of migraines, as well as possible triggers, including food and drink.

If a food, beverage, or additive is identified as a possible trigger, Parikh suggests avoiding it for a month to see what happens. It's important to eliminate only one potential exposure each month, otherwise, you won't be certain what is triggering an attack.

Tracking the impact of a dietary change can help distinguish actual food triggers from migraine-associated food cravings. It's also important to work with a doctor when making any diet changes, says Parikh.

Get your sleep. Sleep and migraine are closely linked. A 2020 review showed the two-way relationship between sleep disorders and migraines. In other words, poor sleep quality is a trigger for migraines, and migraine sufferers are also at an increased risk of sleep disorders. To reduce the risk of sleep as a trigger for migraines, Parikh recommends that her patients stick to a specific sleep schedule.

Reduce stress. Stress can also trigger migraines. In fact, in one study, four out of every five people with migraines reported stress as a trigger. Here are some ways to reduce stress:

Certain foods, drinks, and additives may trigger migraines, and tracking them in a headache diary with one elimination per month may be helpful. Getting good quality sleep, exercise, and reducing stress can also reduce migraine attacks.

Migraines can be brutally painful and life-altering. The causes of migraines are complex and not always known. However, research has shown that there are ways to potentially lessen the frequency, duration, and intensity of attacks.

Parikh emphasizes that it's important to support migraine sufferers and not blame them for trigger exposures that may provoke migraine attacks. "There are many factors that come together to cause migraines, and you can do everything 'right' and still get them," she says.

See original here:
8 foods and drinks that are common migraine triggers, according to a neurologist - Insider - INSIDER

Push Is On in US to Figure Out South Asians High Heart Risks – Kaiser Health News

Posted: November 18, 2020 at 9:52 am

For years, Sharad Acharyas frequent hikes in the mountains outside Denver would leave him short of breath. But a real wake-up call came three years ago when he suddenly struggled to breathe while walking through an airport.

An electrocardiogram revealed that Acharya, a Nepali American from Broomfield, Colorado, had an irregular heartbeat on top of the high blood pressure he already knew about. He had to immediately undergo triple bypass surgery and get seven stents.

Acharya, now 54, thought of his late father and his many uncles who have had heart problems.

Its part of my genetics, for sure, he said.

South Asian Americans people with roots in Nepal, India, Pakistan, Sri Lanka, Bangladesh, Bhutan and the Maldives have a disproportionately higher risk of heart disease and other cardiovascular ailments. Worldwide, South Asians account for 60% of all heart disease cases, even though at 2 billion people they make up only a quarter of the planets population.

In the United States, theres increasing attention on these risks for Americans of South Asian descent, a growing population of about 5.4 million. Health care professionals attribute the problem to a mix of genetic, cultural and lifestyle influences but researchers are advocating for more resources to fully understand it.

Subscribe to KHNs free Morning Briefing.

Rep. Pramila Jayapal (D-Wash.) is sponsoring legislation that would direct $5 million over the next five years toward research into heart disease among South Asian Americans and raising awareness of the issue. The bill passed the U.S. House in September and is up for consideration in the Senate.

The issue could gain more attention after Sen. Kamala Harris (D-Calif.) becomes the nations first vice president with South Asian lineage. Harris mother, Shyamala Gopalan, moved from India to the U.S. in 1958 to attend graduate school. Gopalan, a breast cancer researcher, died in 2009 of colon cancer.

A 2018 study for the American Heart Association found South Asian Americans are more likely to die of coronary heart disease than other Asian Americans and non-Hispanic white Americans. The study pointed to their high incidences of diabetes and prediabetes as risk factors, as well as high waist-to-hip ratios. People of South Asian descent have a higher tendency to gain visceral fat in the abdomen, which is associated with insulin resistance. They also were found to be less physically active than other ethnic groups in the U.S.

One of the nations largest undertakings to understand these risks is the Mediators of Atherosclerosis in South Asians Living in America study, which began in 2006. The MASALA researchers, from institutions such as Northwestern University and the University of California-San Francisco, have examined more than 1,100 South Asian American men and women ages 40-79 to better understand the prevalence and outcomes of cardiovascular disease. They stress that high blood pressure and diabetes are common in the community, even for people at normal weights.

Thats why, said Dr. Alka Kanaya, MASALAs principal investigator and a professor at UCSF, South Asians cannot rely on traditional body mass index metrics, because BMI numbers considered normal could provide false reassurance to those who might still be at risk.

Kanaya recommends cardiac CT scans, which she said help identify high-risk patients, those who need to make more aggressive lifestyle changes and those who may need preventive medication.

Another risk factor, this one cultural, is diet. Some South Asian Americans are vegetarians, though its often a grain-heavy diet reliant on rice and flatbread. The AHA study found risks in such diets, which are high in refined carbohydrates and saturated fat.

We have to understand the cultural nuances [with] an Indian vegetarian diet, said Dr. Ronesh Sinha, author of The South Asian Health Solution and an internal medicine physician. That means something totally different than a Westerner whos going to be consuming a lot of plant-based protein and tofu, eating lots of salads and things that typical South Asians dont.

But getting South Asians to change their eating habits can be challenging, because their culture expresses hospitality and love through food, according to Arnab Mukherjea, an associate professor of health sciences at California State University-East Bay. One of the things South Asians tend to take a lot of pride in is transmitting cultural values and norms knowledge to the next generation, Mukherjea said.

Acharyas health is still an issue. He said he had to get four more stents this year, and the surgeries have put pressure on his family. But hes breathing well, watching what he eats and once more exploring his beloved mountains.(Eli Imadali for KHN)

The intergenerational transmission goes both ways, according to MASALA researchers. Adult, second-generation South Asian Americans might be the key to helping those in the first generation who are resistant to change adopt healthier habits, according to Kanaya.

In the San Francisco Bay Area, El Camino Hospitals South Asian Heart Center is one of the nations leading centers for educating the community. Its three locations are not far from Silicon Valley tech giants, which employ many South Asian Americans.

The centers medical director, Dr. Csar Molina, said the center treats many relatively young patients of South Asian descent without typical risk factors for cardiovascular disease.

It was like the typical 44-year-old engineer with a spouse and two kids showing up with a heart attack, he said.

The South Asian Health Center helps patients make lifestyle changes through meditation, exercise, diet and sleep. The nearby Palo Alto Medical Foundations Prevention and Awareness for South Asians program and the Stanford South Asian Translational Heart Initiative provide medical support for the community. Even patients in the later stages of heart disease can be helped by lifestyle changes, Sinha said.

Dr. Kevin Shah, a University of Utah cardiologist who co-authored the AHA study, said people with diabetes, hypertension and obesity are also at higher risk of COVID-19 complications so should now especially work to improve their cardiovascular health and fitness.

In Colorado, Acharyas health is still an issue. He said he had to get four more stents this year, and the surgeries have put pressure on his family. But hes breathing well, watching what he eats and once more exploring his beloved mountains.

Nowadays, I feel very, very good, he said. Im hiking a lot.

See the article here:
Push Is On in US to Figure Out South Asians High Heart Risks - Kaiser Health News

COVID-19 to Testosterone Replacement Therapy Market Inelastic in Near Term, Projects WMR : AbbVie, Endo International, Eli lilly, Pfizer -…

Posted: November 16, 2020 at 8:57 am

Oct 2020, Latest release fromWMR -Testosterone Replacement Therapy MarketResearch Report 2020-2026(by Product Type, End-User/Application, and Regions/Countries)evaluates each segment of the Premium Testosterone Replacement Therapy market in detail so that readers can be guided about future opportunities and high-profit areas of the industry. It includespresents an encyclopedic study of importantmarket dynamics, including Market Size, Share, Growth Initiators, Trends, Obstacles, Challenges, and opportunities.

The primary objective of theTestosterone Replacement Therapy marketreport is to provide insights regarding opportunities in the market that are supporting the transformation of global businesses associated with Testosterone Replacement Therapy. This report also provides an estimation of the Testosterone Replacement Therapy market size and corresponding revenue forecasts carried out in terms of US$. It also offers actionable insights based on future trends in the Testosterone Replacement Therapy market. Furthermore, new and emerging players in the global Testosterone Replacement Therapy market can make use of the information presented in the study for effective business decisions, which will provide momentum to their businesses as well as the global Testosterone Replacement Therapy market.

Download the FREE sample of this Reporthttps://www.worldwidemarketreports.com/sample/204548

The Major Players covered in this Testosterone Replacement Therapy Market reports are-AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals

The outbreak of the pandemicCOVID-19changed the market scenario on the global platform. Many of the regions are facing the biggest economic crisis owing to the lockdowns that were implemented due to the outspread of the coronavirus infection. As the only solution that has been found to contracting this disease is social distancing many countries have implemented strong regulations in regards to people gatherings. Owing to this many of the businesses are working with only 30% of its employees thus not able to bring the maximum production.

Thiscan affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets.

Get the Latest Updates as well How Covid-19 Affected the Testosterone Replacement Therapy Market in one report:https://www.worldwidemarketreports.com/covidimpact/204548

Market Attributes

Details

The market size value in 2020

USDXX Million

The revenue forecast in 2026

USDXX Million

Growth Rate

CAGR of XX % from 2020 to 2026

Report coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends

Country scope

U.S., Canada, Mexico, U.K., Germany, France, Italy, China, India, Japan, Brazil, Argentina, Saudi Arabia, South Africa

The scope of the report extends from market scenarios to price comparisons between key players, costs, and benefits in specific market regions. Numerical data is backed up with statistical tools such asSWOT analysis, BCG matrix, SCOT analysis, and PESTLE analysis. Statistics are presented in graphical format for a clear understanding of facts and figures.

Do you have any Query or any customization with this report, please get in touch with our business experts at:https://www.worldwidemarketreports.com/quiry/204548

Contact Us:

Mr. ShahWorldwide Market ReportsSeattle, WA 98154,U.S.Email: sales@worldwidemarketreports.com

Read the original:
COVID-19 to Testosterone Replacement Therapy Market Inelastic in Near Term, Projects WMR : AbbVie, Endo International, Eli lilly, Pfizer -...

Testosterone Replacement Therapy Market: Technological Advancement & Growth Analysis with Forecast to 2026 – Eurowire

Posted: November 16, 2020 at 8:57 am

Overview Of Testosterone Replacement Therapy Industry 2020-2026:

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The Testosterone Replacement Therapy Market analysis summary by Reports Insights is a thorough study of the current trends leading to this vertical trend in various regions. Research summarizes important details related to market share, market size, applications, statistics and sales. In addition, this study emphasizes thorough competition analysis on market prospects, especially growth strategies that market experts claim.

Testosterone Replacement Therapy Market competition by top manufacturers as follow: , Endo International, AbbVie, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals,,

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/75680

The global Testosterone Replacement Therapy market has been segmented on the basis of technology, product type, application, distribution channel, end-user, and industry vertical, along with the geography, delivering valuable insights.

The Type Coverage in the Market are: GelsInjectionsPatchesOthers

Market Segment by Applications, covers:HospitalsClinicsOthers

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaRest of Asia PacificCentral & South AmericaMiddle East & Africa

Major factors covered in the report:

To get this report at a profitable rate.: https://reportsinsights.com/discount/75680

The analysis objectives of the report are:

Our report offers:

Market share assessments for the regional and country level segments. Market share analysis of the top industry players. Strategic recommendations for the new entrants. Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets. Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations). Strategic recommendations in key business segments based on the market estimations. Competitive landscaping mapping the key common trends. Company profiling with detailed strategies, financials, and recent developments. Supply chain trends mapping the latest technological advancements.

Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://reportsinsights.com/industry-forecast/Testosterone-Replacement-Therapy-75680

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

See the article here:
Testosterone Replacement Therapy Market: Technological Advancement & Growth Analysis with Forecast to 2026 - Eurowire

Testosterone Replacement Therapy Market Report 2020 Growth of Industry, Manufacturing, Value, Consumption, Status and Forecast for 2027 -…

Posted: November 16, 2020 at 8:57 am

Final Report will add the analysis of the impact of COVID-19 on this industry.

November 2020:

The recent report entitled Global Testosterone Replacement Therapy Market Size, Status and Forecast 2020-2027 offered by Coherent Market Insights, comprises a comprehensive investigation into the geographic landscape, industry size and business revenue estimate. In addition, the report also highlights the challenges that hinder market growth and the expansion strategies employed by leading companies in the Testosterone Replacement Therapy market.

This is the most recent report that includes the effects of COVID-19 on the functioning of the market. It is well known that some changes, for the worse, were managed by the pandemic in all industries. The current scenario of the business sector and the impact of the pandemic on the industrys past and future are addressed in this report.

Get a free sample copy of this [emailprotected]: https://www.coherentmarketinsights.com/insight/request-sample/2024

In the market segmentation by manufacturers, the report covers the following companies:

AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Detailed Segmentation:

By Active Ingredient TypeTestosteroneMethyl TestosteroneTestosterone UndecanoateTestosterone EnanthateTestosterone CypionateBy Route of AdministrationInjectablesParenteral

Testosterone Replacement Therapy Market regional analysis includes:

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)

Europe (Turkey, Germany, Russia, United Kingdom, Italy, France, etc.)

North America (United States, Mexico and Canada).

South America (Brazil etc.)

Middle East and Africa (GCC countries and Egypt).

The survey provides answers to the following key questions:

What is the expected growth rate of the Testosterone Replacement Therapy market? How big will the market be for the forecast period, 2020-2027?

What are the main drivers responsible for transforming the sectors trajectory?

Who are the main suppliers that dominate the Testosterone Replacement Therapy industry in different regions? What are the winning strategies to stay ahead of the competition?

What are the market trends that entrepreneurs can trust in the coming years?

What are the threats and challenges expected to restrict the progress of the industry in different countries?

What are the main opportunities that business owners can take advantage of for the 2020-2027 forecast period?

Why choose CMI?

Need a discount?

Note: *The discount is offered on the Standard Price of the report.

Ask for the discount @ https://www.coherentmarketinsights.com/insight/request-discount/2024

Regional Demand Estimation and Forecast

Pre-commodity price volatility

Analysis of technological updates

Analysis of Location Quotients

Competitive analysis

Matrix of product mix

Supplier management

Cost-benefit analysis

Supply chain optimization analysis

Patent Analysis

Carbon footprint analysis

R&D analysis

Fusions and acquisitions

Contact us for any query or to get a personalized [emailprotected]: https://www.coherentmarketinsights.com/insight/request-customization/2024

NOTE:Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details

Interested about who is winning the race of COVID-19 Vaccine. Coherent Market Insights (CMI)

providesCOVID-19 Vaccine Trackerfor all the latest updates about COVID-19 Vaccine.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact Us:

Mr. ShahCoherent Market Insights1001 4th Ave,#3200Seattle, WA 98154Tel: +1-206-701-6702Email: [emailprotected]

Read more from the original source:
Testosterone Replacement Therapy Market Report 2020 Growth of Industry, Manufacturing, Value, Consumption, Status and Forecast for 2027 -...

Testosterone Replacement Therapy Market Overview, Development History And Forecast To Shared In Latest Research Report 2020-2026 |Endo International,…

Posted: November 16, 2020 at 8:57 am

The global Testosterone Replacement Therapy market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Testosterone Replacement Therapy market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global Testosterone Replacement Therapy market. The authors of the report profile leading companies of the global Testosterone Replacement Therapy market, such as AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals They provide details about important activities of leading players in the competitive landscape.

The report predicts the size of the global Testosterone Replacement Therapy market in terms of value and volume for the forecast period 2019-2026. As per the analysis provided in the report, the global Testosterone Replacement Therapy market is expected to rise at a CAGR of XX % between 2019 and 2026 to reach a valuation of US$ XX million/billion by the end of 2026. In 2018, the global Testosterone Replacement Therapy market attained a valuation of US$_ million/billion. The market researchers deeply analyze the global Testosterone Replacement Therapy industry landscape and the future prospects it is anticipated to create.

This publication includes key segmentations of the global Testosterone Replacement Therapy market on the basis of product, application, and geography (country/region). Each segment included in the report is studied in relation to different factors such as consumption, market share, value, growth rate, and production.

Get Sample Copy of This Report:https://www.qyresearch.com/sample-form/form/1510148/global-testosterone-replacement-therapy-industry

The comparative results provided in the report allow readers to understand the difference between players and how they are competing against each other. The research study gives a detailed view of current and future trends and opportunities of the global Testosterone Replacement Therapy market. Market dynamics such as drivers and restraints are explained in the most detailed and easiest manner possible with the use of tables and graphs. Interested parties are expected to find important recommendations to improve their business in the global Testosterone Replacement Therapy market.

Readers can understand the overall profitability margin and sales volume of various products studied in the report. The report also provides the forecasted as well as historical annual growth rate and market share of the products offered in the global Testosterone Replacement Therapy market. The study on end-use application of products helps to understand the market growth of the products in terms of sales.

Global Testosterone Replacement Therapy Market by Product: , Gels, Injections, Patches, Other Market

Global Testosterone Replacement Therapy Market by Application: Hospitals, Clinics, Others

The report also focuses on the geographical analysis of the global Testosterone Replacement Therapy market, where important regions and countries are studied in great detail.

Global Testosterone Replacement Therapy Market by Geography:

Methodology

Our analysts have created the report with the use of advanced primary and secondary research methodologies.

As part of primary research, they have conducted interviews with important industry leaders and focused on market understanding and competitive analysis by reviewing relevant documents, press releases, annual reports, and key products.

For secondary research, they have taken into account the statistical data from agencies, trade associations, and government websites, internet sources, technical writings, and recent trade information.

Enquire For Customization in the Report:https://www.qyresearch.com/customize-request/form/1510148/global-testosterone-replacement-therapy-industry

Key questions answered in the report:

Table Of Contents:

Table of Contents 1 Report Overview1.1 Research Scope1.2 Top Testosterone Replacement Therapy Manufacturers Covered: Ranking by Revenue1.3 Market Segment by Type1.3.1 Global Testosterone Replacement Therapy Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)1.3.2 Gels1.3.3 Injections1.3.4 Patches1.3.5 Other1.4 Market Segment by Application1.4.1 Global Testosterone Replacement Therapy Consumption by Application: 2015 VS 2020 VS 20261.4.2 Hospitals1.4.3 Clinics1.4.4 Others1.5 Study Objectives1.6 Years Considered 2 Global Market Perspective2.1 Global Testosterone Replacement Therapy Revenue (2015-2026)2.1.1 Global Testosterone Replacement Therapy Revenue (2015-2026)2.1.2 Global Testosterone Replacement Therapy Sales (2015-2026)2.2 Testosterone Replacement Therapy Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 20262.2.1 Global Testosterone Replacement Therapy Sales by Regions (2015-2020)2.2.2 Global Testosterone Replacement Therapy Revenue by Regions (2015-2020)2.3 Global Top Testosterone Replacement Therapy Regions (Countries) Ranking by Market Size2.4 Testosterone Replacement Therapy Industry Trends2.4.1 Testosterone Replacement Therapy Market Top Trends2.4.2 Market Drivers2.4.3 Testosterone Replacement Therapy Market Challenges 2.4.4 Porters Five Forces Analysis2.4.5 Primary Interviews with Key Testosterone Replacement Therapy Players: Views for Future 3 Competitive Landscape by Manufacturers3.1 Global Top Testosterone Replacement Therapy Manufacturers by Sales (2015-2020)3.1.1 Global Testosterone Replacement Therapy Sales by Manufacturers (2015-2020)3.1.2 Global Testosterone Replacement Therapy Sales Market Share by Manufacturers (2015-2020)3.1.3 Global 5 and 10 Largest Manufacturers by Testosterone Replacement Therapy Sales in 20193.2 Global Top Manufacturers Testosterone Replacement Therapy by Revenue3.2.1 Global Testosterone Replacement Therapy Revenue by Manufacturers (2015-2020)3.2.2 Global Testosterone Replacement Therapy Revenue Share by Manufacturers (2015-2020)3.2.3 Global Testosterone Replacement Therapy Market Concentration Ratio (CR5 and HHI)3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Testosterone Replacement Therapy as of 2019)3.4 Global Testosterone Replacement Therapy Average Selling Price (ASP) by Manufacturers3.5 Key Manufacturers Testosterone Replacement Therapy Plants/Factories Distribution and Area Served3.6 Date of Key Manufacturers Enter into Testosterone Replacement Therapy Market3.7 Key Manufacturers Testosterone Replacement Therapy Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type4.1 Global Testosterone Replacement Therapy Historic Market Review by Type (2015-2020)4.1.2 Global Testosterone Replacement Therapy Sales Market Share by Type (2015-2020)4.1.3 Global Testosterone Replacement Therapy Revenue Market Share by Type (2015-2020)4.1.4 Testosterone Replacement Therapy Price by Type (2015-2020)4.1 Global Testosterone Replacement Therapy Market Estimates and Forecasts by Type (2021-2026)4.2.2 Global Testosterone Replacement Therapy Sales Forecast by Type (2021-2026)4.2.3 Global Testosterone Replacement Therapy Revenue Forecast by Type (2021-2026)4.2.4 Testosterone Replacement Therapy Price Forecast by Type (2021-2026) 5 Global Testosterone Replacement Therapy Market Size by Application5.1 Global Testosterone Replacement Therapy Historic Market Review by Application (2015-2020)5.1.2 Global Testosterone Replacement Therapy Sales Market Share by Application (2015-2020)5.1.3 Global Testosterone Replacement Therapy Revenue Market Share by Application (2015-2020)5.1.4 Testosterone Replacement Therapy Price by Application (2015-2020)5.2 Global Testosterone Replacement Therapy Market Estimates and Forecasts by Application (2021-2026)5.2.2 Global Testosterone Replacement Therapy Sales Forecast by Application (2021-2026)5.2.3 Global Testosterone Replacement Therapy Revenue Forecast by Application (2021-2026)5.2.4 Testosterone Replacement Therapy Price Forecast by Application (2021-2026) 6 North America6.1 North America Testosterone Replacement Therapy Breakdown Data by Company6.2 North America Testosterone Replacement Therapy Breakdown Data by Type6.3 North America Testosterone Replacement Therapy Breakdown Data by Application6.4 North America Testosterone Replacement Therapy Breakdown Data by Countries6.4.1 North America Testosterone Replacement Therapy Sales by Countries6.4.2 North America Testosterone Replacement Therapy Revenue by Countries6.4.3 U.S.6.4.4 Canada 7 Europe7.1 Europe Testosterone Replacement Therapy Breakdown Data by Company7.2 Europe Testosterone Replacement Therapy Breakdown Data by Type7.3 Europe Testosterone Replacement Therapy Breakdown Data by Application7.4 Europe Testosterone Replacement Therapy Breakdown Data by Countries7.4.1 Europe Testosterone Replacement Therapy Sales by Countries7.4.2 Europe Testosterone Replacement Therapy Revenue by Countries7.4.3 Germany7.4.4 France7.4.5 U.K.7.4.6 Italy7.4.7 Russia 8 Asia Pacific8.1 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Company8.2 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Type8.3 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Application8.4 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Regions8.4.1 Asia Pacific Testosterone Replacement Therapy Sales by Regions8.4.2 Asia Pacific Testosterone Replacement Therapy Revenue by Regions8.4.3 China8.4.4 Japan8.4.5 South Korea8.4.6 India8.4.7 Australia8.4.8 Taiwan8.4.9 Indonesia8.4.10 Thailand8.4.11 Malaysia8.4.12 Philippines8.4.13 Vietnam 9 Latin America9.1 Latin America Testosterone Replacement Therapy Breakdown Data by Company9.2 Latin America Testosterone Replacement Therapy Breakdown Data by Type9.3 Latin America Testosterone Replacement Therapy Breakdown Data by Application9.4 Latin America Testosterone Replacement Therapy Breakdown Data by Countries9.4.1 Latin America Testosterone Replacement Therapy Sales by Countries9.4.2 Latin America Testosterone Replacement Therapy Revenue by Countries9.4.3 Mexico9.4.4 Brazil9.4.5 Argentina 10 Middle East and Africa10.1 Middle East and Africa Testosterone Replacement Therapy Breakdown Data by Type10.2 Middle East and Africa Testosterone Replacement Therapy Breakdown Data by Application10.3 Middle East and Africa Testosterone Replacement Therapy Breakdown Data by Countries10.3.1 Middle East and Africa Testosterone Replacement Therapy Sales by Countries10.3.2 Middle East and Africa Testosterone Replacement Therapy Revenue by Countries10.3.3 Turkey10.3.4 Saudi Arabia10.3.5 U.A.E 11 Company Profiles11.1 AbbVie11.1.1 AbbVie Corporation Information11.1.2 AbbVie Business Overview and Total Revenue (2019 VS 2018)11.1.3 AbbVie Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.1.4 AbbVie Testosterone Replacement Therapy Products and Services11.1.5 AbbVie SWOT Analysis11.1.6 AbbVie Recent Developments11.2 Endo International11.2.1 Endo International Corporation Information11.2.2 Endo International Business Overview and Total Revenue (2019 VS 2018)11.2.3 Endo International Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.2.4 Endo International Testosterone Replacement Therapy Products and Services11.2.5 Endo International SWOT Analysis11.2.6 Endo International Recent Developments11.3 Eli lilly11.3.1 Eli lilly Corporation Information11.3.2 Eli lilly Business Overview and Total Revenue (2019 VS 2018)11.3.3 Eli lilly Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.3.4 Eli lilly Testosterone Replacement Therapy Products and Services11.3.5 Eli lilly SWOT Analysis11.3.6 Eli lilly Recent Developments11.4 Pfizer11.4.1 Pfizer Corporation Information11.4.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)11.4.3 Pfizer Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.4.4 Pfizer Testosterone Replacement Therapy Products and Services11.4.5 Pfizer SWOT Analysis11.4.6 Pfizer Recent Developments11.5 Actavis (Allergan)11.5.1 Actavis (Allergan) Corporation Information11.5.2 Actavis (Allergan) Business Overview and Total Revenue (2019 VS 2018)11.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.5.4 Actavis (Allergan) Testosterone Replacement Therapy Products and Services11.5.5 Actavis (Allergan) SWOT Analysis11.5.6 Actavis (Allergan) Recent Developments11.6 Bayer11.6.1 Bayer Corporation Information11.6.2 Bayer Business Overview and Total Revenue (2019 VS 2018)11.6.3 Bayer Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.6.4 Bayer Testosterone Replacement Therapy Products and Services11.6.5 Bayer SWOT Analysis11.6.6 Bayer Recent Developments11.7 Novartis11.7.1 Novartis Corporation Information11.7.2 Novartis Business Overview and Total Revenue (2019 VS 2018)11.7.3 Novartis Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.7.4 Novartis Testosterone Replacement Therapy Products and Services11.7.5 Novartis SWOT Analysis11.7.6 Novartis Recent Developments11.8 Teva11.8.1 Teva Corporation Information11.8.2 Teva Business Overview and Total Revenue (2019 VS 2018)11.8.3 Teva Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.8.4 Teva Testosterone Replacement Therapy Products and Services11.8.5 Teva SWOT Analysis11.8.6 Teva Recent Developments11.9 Mylan11.9.1 Mylan Corporation Information11.9.2 Mylan Business Overview and Total Revenue (2019 VS 2018)11.9.3 Mylan Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.9.4 Mylan Testosterone Replacement Therapy Products and Services11.9.5 Mylan SWOT Analysis11.9.6 Mylan Recent Developments11.10 Upsher-Smith11.10.1 Upsher-Smith Corporation Information11.10.2 Upsher-Smith Business Overview and Total Revenue (2019 VS 2018)11.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.10.4 Upsher-Smith Testosterone Replacement Therapy Products and Services11.10.5 Upsher-Smith SWOT Analysis11.10.6 Upsher-Smith Recent Developments11.11 Ferring Pharmaceuticals11.11.1 Ferring Pharmaceuticals Corporation Information11.11.2 Ferring Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)11.11.3 Ferring Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.11.4 Ferring Pharmaceuticals Testosterone Replacement Therapy Products and Services11.11.5 Ferring Pharmaceuticals SWOT Analysis11.11.6 Ferring Pharmaceuticals Recent Developments11.12 Kyowa Kirin11.12.1 Kyowa Kirin Corporation Information11.12.2 Kyowa Kirin Business Overview and Total Revenue (2019 VS 2018)11.12.3 Kyowa Kirin Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.12.4 Kyowa Kirin Testosterone Replacement Therapy Products and Services11.12.5 Kyowa Kirin SWOT Analysis11.12.6 Kyowa Kirin Recent Developments11.13 Acerus Pharmaceuticals11.13.1 Acerus Pharmaceuticals Corporation Information11.13.2 Acerus Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)11.13.3 Acerus Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.13.4 Acerus Pharmaceuticals Testosterone Replacement Therapy Products and Services11.13.5 Acerus Pharmaceuticals SWOT Analysis11.13.6 Acerus Pharmaceuticals Recent Developments 12 Supply Chain and Sales Channels Analysis 12.1 Supply Chain Analysis 12.2 Sales Channels Analysis12.2.1 Testosterone Replacement Therapy Sales Channels12.2.2 Testosterone Replacement Therapy Distributors12.3 Testosterone Replacement Therapy Customers 13 Estimates and Projections by Regions (2021-2026)13.1 Global Testosterone Replacement Therapy Sales Forecast (2021-2026)13.1.1 Global Testosterone Replacement Therapy Sales Forecast by Regions (2021-2026)13.1.2 Global Testosterone Replacement Therapy Revenue Forecast by Regions (2021-2026) 13.2 North America Market Size Forecast (2021-2026)13.2.1 North America Testosterone Replacement Therapy Sales Forecast (2021-2026)13.2.2 North America Testosterone Replacement Therapy Revenue Forecast (2021-2026)13.2.3 North America Testosterone Replacement Therapy Size Forecast by County (2021-2026) 13.3 Europe Market Size Forecast (2021-2026)13.3.1 Europe Testosterone Replacement Therapy Sales Forecast (2021-2026)13.3.2 Europe Testosterone Replacement Therapy Revenue Forecast (2021-2026)13.3.3 Europe Testosterone Replacement Therapy Size Forecast by County (2021-2026) 13.4 Asia Pacific Market Size Forecast (2021-2026)13.4.1 Asia Pacific Testosterone Replacement Therapy Sales Forecast (2021-2026)13.4.2 Asia Pacific Testosterone Replacement Therapy Revenue Forecast (2021-2026)13.4.3 Asia Pacific Testosterone Replacement Therapy Size Forecast by Region (2021-2026) 13.5 Latin America Market Size Forecast (2021-2026)13.5.1 Latin America Testosterone Replacement Therapy Sales Forecast (2021-2026)13.5.2 Latin America Testosterone Replacement Therapy Revenue Forecast (2021-2026)13.5.3 Latin America Testosterone Replacement Therapy Size Forecast by County (2021-2026) 13.6 Middle East and Africa Market Forecast13.6.1 Middle East and Africa Testosterone Replacement Therapy Sales Forecast (2021-2026)13.6.2 Middle East and Africa Testosterone Replacement Therapy Revenue Forecast (2021-2026)13.6.3 Middle East and Africa Testosterone Replacement Therapy Size Forecast by County (2021-2026) 14 Research Findings and Conclusion 15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Author Details15.3 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

See the article here:
Testosterone Replacement Therapy Market Overview, Development History And Forecast To Shared In Latest Research Report 2020-2026 |Endo International,...

Triumphs and hardships as pro hockey’s 1st openly transgender woman – CBC.ca

Posted: November 16, 2020 at 8:57 am

As a child growing up in Brights Grove, Ont., Jessica Platt lived for hockey. For her, being on the ice was "when everything made sense."

But off the ice, it was a different story.

For years, Platt struggled with feeling as though she didn't fit in with the other boys, and hated being in the locker room.

By her teens, she would leave the game she loved, and nearlyseven years would pass before she played hockey again.

Platt, now of Kitchener, Ont., shares hertriumphs and struggles in a chapter of the new book, Everyday Hockey Heroes Volume II, by sports journalists Bob McKenzie and Jim Lang. Platt is the author ofthe chapter titled 'Simply A Hockey Player'.

"It took a lot for me to share my story like this," Platt told CBC Radio's Afternoon Drive. "I typically like to focus on the positive aspects, but I had to highlight some of the negative things that I had been through in my life and had to overcome. So it was difficult to write it."

In the book, Platt looks back on the seven years she spent away from hockey. She moved from Brights Groveto Waterloo, Ont. for university, but not before undergoing hormone replacement therapy (HRT). The physical changes that accompanied the therapy meant a significant loss in her athletic ability.

"A lot of people think that to be a transgender woman playing sportsyou just simply have to identify as a woman," Platt said. "But at the elite levels, you have to undergo medical intervention. And the lack of testosterone in your bodydefinitely decreases your speed, your strength, pretty much everything. You have to get used to a new normal."

After beginning hormone replacement therapy and eventually transitioning her gender, Platt played professional for the Toronto Furies of the now-defunct Canadian Women's Hockey League team.

In 2018, she became the first openly transgender woman in North American professional hockey.

Despite having supportive teammates who she could trust, Platt reflected on the nerve-wracking experience of coming out to coaches, staff, and eventually the entire league.

"Absolutely terrifying," Platt recalled of the experience."I was petrified to potentially feel like I didn't belong in the dressing room again, like I had fought so long for growing up."

"But thankfully, I got nothing but positive responses and support from my teammates and my coaches. And that was truly incredible."

The book Everyday Hockey Heroes Volume IIwas released earlier this week by Simon & Schuster. Take a listen belowto Afternoon Drive'sfull interview with Jessica Platt.

Afternoon Drive8:24Transgender hockey player shares experience in new book

Link:
Triumphs and hardships as pro hockey's 1st openly transgender woman - CBC.ca

The One Thing All Successful Weight Loss Diets Have in Common – msnNOW

Posted: November 16, 2020 at 8:55 am

Shutterstock dumbbells sitting next to a scale with measuring tape and a green apple

Remember when that science teacher John Cisna made headlines back in 2015 for losing more than 55 pounds in six months while eating only McDonald's foods?

How did he do it? By limiting his caloric intake to 2,000 calories per day and exercising regularly. While a diet largely consisting of French fries and burgers and other foods high in fats may not be ideal for your heart or arteries, Cisna's unique experiment proved that calorie regulation is the key to weight loss.

And in fact, a caloric deficit is the primary reason any specific type of diet can lead to weight loss. (Related: 100 Unhealthiest Foods on the Planet.)

One observational study of a group of Paleo Diet followers found that followers of the heart-healthy diet lost an average of five pounds over a three week period, but this weight loss came not only with a shift to eschewing beans, grains, sugar, dairy, and certain other proscribed foods, but also with an approximate drop of 500 calories consumed per day.

Ketogenic diets, wherein followers consume lots of fats, some protein, and very few carbohydrates, have proven to be as or even more effective than low-fat diets for efficiency of weight loss. But in one study cited by Healthline, both the keto and low-fat dieters "reduced calorie consumption," with lowered caloric intake driving the weight loss.

A Mayo Clinic analysis of the Atkins Diet concluded that: "Because carbohydrates usually provide over half of calories consumed, the main reason for weight loss on the Atkins Diet is lower overall calorie intake from eating less carbs."

And on it goes as you consider the Dukan Diet, the HCG Diet, a vegan diet, and so forth. To lose weight, you must ingest less and burn more calories.

For more weight loss news, make sure to sign up for our newsletter.

Read the original article on Eat This, Not That!

Read the original post:
The One Thing All Successful Weight Loss Diets Have in Common - msnNOW


Page 419«..1020..418419420421..430440..»